Raphael Pharmaceutical is trading at 1.0 as of the 1st of March 2025. This is a No Change since the beginning of the trading day. The stock's open price was 1.0. Raphael Pharmaceutical has 51 percent odds of going through some form of financial distress in the next two years but had a very solid returns during the last 90 days. The performance scores are derived for the period starting the 12th of March 2023 and ending today, the 1st of March 2025. Click here to learn more.
Picking the right benchmark for Raphael Pharmaceutical otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Raphael Pharmaceutical otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Raphael Pharmaceutical is critical whether you are bullish or bearish towards Raphael Pharmaceutical at a given time. Please also check how Raphael Pharmaceutical's historical prices are related to one of the top price index indicators.
Our tools can tell you how much better you can do entering a position in Raphael Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Bonds Directory Now
Bonds Directory
Find actively traded corporate debentures issued by US companies
Other Information on Investing in Raphael OTC Stock
Raphael Pharmaceutical financial ratios help investors to determine whether Raphael OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Raphael with respect to the benefits of owning Raphael Pharmaceutical security.